Australia: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Australia

The Australian medicaments containing corticosteroid hormones market amounted to $X in 2021, picking up by 4.2% against the previous year. Over the period under review, the total consumption indicated a modest increase from 2012 to 2021: its value increased at an average annual rate of +1.5% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption decreased by -13.5% against 2019 indices. Medicaments containing corticosteroid hormones consumption peaked at $X in 2019; however, from 2020 to 2021, consumption failed to regain momentum.

Production of Medicaments Containing Corticosteroid Hormones in Australia

In value terms, medicaments containing corticosteroid hormones production soared to $X in 2021 estimated in export price. Overall, production continues to indicate a significant expansion. The pace of growth was the most pronounced in 2017 when the production volume increased by 473%. Medicaments containing corticosteroid hormones production peaked at $X in 2019; however, from 2020 to 2021, production stood at a somewhat lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports from Australia

In 2021, the amount of medicaments containing corticosteroid hormones exported from Australia soared to X tons, increasing by 17% compared with the year before. Over the period under review, exports showed strong growth. The growth pace was the most rapid in 2017 when exports increased by 265% against the previous year. Over the period under review, the exports reached the peak figure in 2021 and are expected to retain growth in the near future.

In value terms, medicaments containing corticosteroid hormones exports fell modestly to $X in 2021. In general, exports continue to indicate a significant increase. The most prominent rate of growth was recorded in 2017 when exports increased by 546%. The exports peaked at $X in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Papua New Guinea (X tons), France (X tons) and China (X tons) were the main destinations of medicaments containing corticosteroid hormones exports from Australia, with a combined 45% share of total exports. These countries were followed by New Zealand, Turkey, the United States, the UK and Fiji, which together accounted for a further 39%.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by the United States (with a CAGR of +135.8%), while the other leaders experienced more modest paces of growth.

In value terms, the largest markets for medicaments containing corticosteroid hormones exported from Australia were Turkey ($X), France ($X) and China ($X), with a combined 67% share of total exports.

France, with a CAGR of +104.5%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average medicaments containing corticosteroid hormones export price stood at $X per ton in 2021, falling by -15.7% against the previous year. In general, the export price, however, enjoyed a perceptible expansion. The pace of growth was the most pronounced in 2017 an increase of 77% against the previous year. Over the period under review, the average export prices hit record highs at $X per ton in 2018; however, from 2019 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major foreign markets. In 2021, the country with the highest price was Turkey ($X per ton), while the average price for exports to Papua New Guinea ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to China (+2.3%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into Australia

In 2021, purchases abroad of medicaments containing corticosteroid hormones increased by 2.2% to X tons, rising for the second year in a row after three years of decline. In general, imports, however, recorded a slight decline. The most prominent rate of growth was recorded in 2015 when imports increased by 12% against the previous year. Over the period under review, imports hit record highs at X tons in 2016; however, from 2017 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing corticosteroid hormones imports expanded slightly to $X in 2021. Over the period under review, imports, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 when imports increased by 28% against the previous year. Imports peaked at $X in 2013; however, from 2014 to 2021, imports remained at a lower figure.

Imports by Country

France (X tons), Belgium (X tons) and the UK (X tons) were the main suppliers of medicaments containing corticosteroid hormones imports to Australia, together accounting for 45% of total imports. These countries were followed by Germany, Spain, Sweden, the United States, Greece, Italy, India, Singapore, Austria and Switzerland, which together accounted for a further 45%.

From 2012 to 2021, the biggest increases were recorded for Greece (with a CAGR of +77.3%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones suppliers to Australia were the UK ($X), Germany ($X) and Belgium ($X), together accounting for 36% of total imports. France, the United States, Switzerland, Spain, Sweden, Italy, Austria, India, Singapore and Greece lagged somewhat behind, together accounting for a further 46%.

Greece, with a CAGR of +46.1%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the average medicaments containing corticosteroid hormones import price amounted to $X per ton, leveling off at the previous year. Overall, the import price showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 an increase of 29%. The import price peaked in 2021 and is expected to retain growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Switzerland ($X per ton), while the price for Greece ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by India (+17.8%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :